Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Not yet recruiting	Phase 1 / Phase 2	2026-09-21		NCT07831187

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital of Wenzhou Medical University	117
Jinhua Municipal Central Hospital	14
Second Affiliated Hospital, Zhejiang University, School of Medicine	561

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Wenzhou Medical University	Wenzhou	China	87